Our Story
In 2015, modalities were changing, pharma was outsourcing R&D at higher rates and acquisition became a primary pathway for innovation. Science was moving faster and would increasingly require skillsets and infrastructures that allowed resources and environments to change as quickly as the research did. We realized the way science was being supported was not going to work in the future.
We thought about how to make science better, faster, and more effective. We explored how to use data and new technologies to develop, operate, and deploy resources for the next generation of science.
We imagined having any kind of lab, at any size, available immediately, with no lease, build out, or infrastructure required. We envisioned an enterprise lab platform where scientists could do any type of research on-demand.
Then we created it.
We built a novel infrastructure with flexibility, which allows your team to work in a private lab configured to your specific research needs, that can be made ready within weeks and adapt and change as quickly as your science evolves.
For the first time, you can outsource your lab's infrastructure, but retain your scientists, workflows, and intellectual property.
That’s how we transformed labs into SmartLabs.
Why we do what we do
What do we care about?
Why do we get up in the morning?
This is what it boils down to.

MISSION
To benefit health and humanity, we radically transform how the world uses labs spaces by delivering customized labs that deploy within weeks, and can grow and change as quickly as research needs evolve.
VISION
To accelerate the pace of science for everyone, everywhere.
PURPOSE
To accelerate the number of effective therapeutics available in the market when we need them and when our loved ones need them.
Our Leadership
June 07,2023

Amrit Chaudhuri
Chief Executive Officer/ Co-Founder



Amrit Chaudhuri
Chief Executive Officer/ Co-Founder
Amrit spent his first eight years in the industry working with hundreds of R&D leaders at universities, biotechs, and large pharma companies to develop commercial products from discovery to market approval.
- Founded Advanced Peptides in 2007, a biopharma CRO
- Holds patents in chemistry for global commercialized products
- One of INC Magazine’s top 20 innovators in healthcare

Seth Taylor, PhD
Chief Business Officer/Co-Founder



Seth Taylor, PhD
Chief Business Officer/Co-Founder
Seth spent his first six years in the industry working in corporate business development and as a startup entrepreneur in high throughput biology, followed by 12 years as a growth strategy consultant for Fortune 500 biopharma.
- In 1999 founded Molecularware, winning the MIT 50K competition, and successfully exited in 2003
- As Principal at TSG partners and Managing General Partner at Vectur LLC, Seth focused on corporate growth and buy-side M&A, as well as VC backed startup sell-side M&A

Amelia Newbury
Executive VP of People and Process



Amelia Newbury
Executive VP of People and Process
Amelia has more than 20 years of experience creating and growing businesses. She has launched and grown five companies from start-up to success by creating winning strategies and high-performance teams that drive growth. Amelia has a unique understanding of how to structure people, culture, and process to fuel high-growth companies.
- Culture and people management expert for early-stage and post Series B companies; has held multiple C-level titles
- Previously Associate Partner and Pharma industry consultant for Monitor Group (now Monitor Deloitte)

Brian Taylor
Executive VP of Biopharma Solutions



Brian Taylor
Executive VP of Biopharma Solutions
Brian is a biopharmaceutical manufacturing expert with more than 20 years of experience in the industry. He comes to SmartLabs from a mid-sized molecular engineering company, where he ran their healthcare business. Prior to that, he was the GM for GE Healthcare’s Biomanufacturing Solutions business.
- Developed turnkey manufacturing solutions for mAb production with a single use platform
- Worked with Congress to bring generic manufacturing back to the US
- Launched and ran cGMP sites, most recently a facility in Spain

Saquib Butt
SVP of Infrastructure & Assets



Saquib Butt
SVP of Infrastructure & Assets
Saquib came to SmartLabs from Boston Scientific, where he was the Head of Global Design and Construction. Saquib has more than 20 years of experience building R&D Laboratory and GMP manufacturing facilities, including the new 500K SQFT Boston Scientific facility in Malaysia.
- Prior responsibilities of managing 9M SQFT across 150 sites in 12 countries
- Led design and construction of over 2M SQFT
- Experience rooted in commercial clean rooms, FDA validated GMP, R&D facilities, and utility infrastructures

Hans Ludi, PhD
SVP of Quality



Hans Ludi, PhD
SVP of Quality
Hans has decades of experience in life science and technology companies while holding a variety of technical and management positions. Throughout his career, he has focused on commercializing advanced technology projects in partnership with corporations and VCs.
- Built and led the global diagnostics platform RAPIDPoint at Novartis and Bayer
- Winner of 2 R&D 100 awards in life sciences
- Multiple positions as CEO and COO

Jillian McLaughlin
VP of Corporate Strategy & Development



Jillian McLaughlin
VP of Corporate Strategy & Development
Jillian came to SmartLabs from New York City government, where she held several leadership and strategic advisor positions. She has nearly a decade of experience in real estate transactions and development, public-private partnerships, and large-scale capital strategy and planning.
- Created a strategic plan to complete $13B of comprehensive renovations for public housing leveraging multiple sources of capital and partnerships
- Led the development of a new state-of-the-art tech hub in Union Square
- Developed and executed policies to fight the COVID-19 pandemic in New York City, execute large-scale capital projects, and streamline internal operations

Robin Feeney
VP of Accounting and FP&A



Robin Feeney
VP of Accounting and FP&A
Robin came to SmartLabs with over 25 years of experience in auditing and developing finance functions at companies of all sizes and across a variety of industries; she has spent the last thirteen years focused on Biotechnology and Healthcare. Robin began her professional at Big Four firms PwC and Deloitte, then moved into global companies Bank of America and Fidelity Investments to continue her focus on internal controls and internal financial operations. She eventually transitioned to smaller companies where she applied her expertise in internal controls to strengthen their finance functions, develop financial operations in early stages of corporate growth, as well as create initial budgets and cash forecasting models that ensure both scalability and the ability to forecast and predict growth patterns that align with overall corporate strategies.
- Has been involved in a variety of M&A transactions, raising more than $350 million in debt and equity deals, and working closely with multiple Private Equity and Investment Banking firms
- The first CFO at StrataDx, where the company grew to $30 million in revenue during her tenure
- Led a new department at Bank of America, overseeing the reconciliation and financial controls of the Bank's internal deposit and general ledger accounts

Cole Young
General Counsel



Cole Young
General Counsel
Cole has been working with SmartLabs since its inception and has been an integral part of its growth over the years. A civil engineer and attorney who is passionate about real estate, construction, and development. Cole has worked with developers, as well as real estate and property management companies of all sizes throughout the country.
- Was a partner at the dynamic business transaction and litigation firm Strang Scott where he served as counsel for businesses of all sizes on matters ranging from business formation and complex commercial transactions to all forms of dispute resolution.
- Founded Woodward Cass, a business law firm representing biotech and pharma companies with clients ranging from initial start-ups to large, national companies

Ben Shaw
VP of Finance Strategy



Ben Shaw
VP of Finance Strategy
Working as a trusted partner to CEOs, Ben has raised over $1 billion of equity, debt, and project capital for 12 companies and completed 11 Merger and Acquisition transactions during his career.
- Former head of finance for Cambridge Innovation Center
- Previous Management Consultant at McKinsey
- Brought investment banking and asset management divisions of Credit Suisse to Middle East

GRAHAM LONG, PHD
VP of Client Solutions



GRAHAM LONG, PHD
VP of Client Solutions
A seasoned Sales and Marketing professional, Graham is also an experienced molecular biologist and former cancer research scientist. Blending his expertise in the lab with his methodical sales and business development talents, Graham has helped grow companies like DiscoverX (acquired by Eurofins), Artel, and PerkinElmer.
- Successful sales penetration into 85% of the top 30 worldwide biopharma
- Full R&D value chain sales development: discovery to clinical stage